BB Biotech(GB:0JYO)
CHFÂ 54.20-0.40 (-0.73%)
GB:0JYO
BB Biotech financials statements
CHFÂ 54.20
At close:-0.40 (-0.73%)
BB Biotech (0JYO) Income Statement
4 Followers
BB Biotech Income Statement
Last quarter (Q3 2026), BB Biotech's total revenue was CHF94.46M, an increase of 349.40% from the same quarter last year. In Q3, BB Biotech's net income was CHF175.03M. See BB Biotech’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| CHF 76.81M | CHF 111.63M | CHF 35.00K | CHF 4.00K | CHF -396.22M | |
| CHF 76.76M | CHF 111.63M | CHF 35.00K | CHF 4.00K | CHF -396.22M | |
| CHF -510.08M | CHF 27.23M | CHF 29.96M | CHF 38.63M | CHF 52.59M | |
| Depreciation and Amortization | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 |
| CHF 578.64M | CHF 80.33M | CHF -34.60M | CHF -43.01M | CHF -59.20M | |
| CHF 586.83M | CHF 84.40M | CHF -29.93M | CHF -38.62M | CHF -52.59M | |
| CHF -8.63M | CHF -8.45M | CHF -176.60M | CHF -319.13M | CHF -352.15M | |
| CHF 578.20M | CHF 75.95M | CHF -206.53M | CHF -357.75M | CHF -404.74M | |
| CHF 578.13M | CHF 75.90M | CHF -206.61M | CHF -357.81M | CHF -404.81M | |
| Per Share Metrics | |||||
| Basic EPS | CHF 10.54 | CHF 1.38 | CHF -3.77 | CHF -6.50 | CHF -7.31 |
| Diluted EPS | CHF 10.54 | CHF 1.38 | CHF -3.77 | CHF -6.46 | CHF -7.31 |
| Weighted Average Shares Outstanding | 54.85M | 54.83M | 54.80M | 55.01M | 55.36M |
| Weighted Average Shares Outstanding (Diluted) | 54.85M | 54.83M | 54.85M | 55.36M | 55.36M |
Currency in CHF
